Journal of Laparoendoscopic & Advanced Surgical Techniques-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1093489, encodeId=c23f109348996, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802963, encodeId=fb328029630f, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：腔镜手术 经验分享：提交后没想到5天之后直接接收了。至今遇到最快的一次投稿。不要版面费审稿费，大约1个月内见刊，唯一的缺点就是if太低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95922353921, createdName=Collection3232, createdTime=Thu Jul 16 09:02:37 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895393, encodeId=1381895393cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a><a href='/topic/show?id=3d378563931' target=_blank style='color:#2F92EE;'>#腹腔镜胃癌根治术#</a>投了10天之后给了小修，但最后因为检验效能不够（样本量小）给拒了。不过杂志审稿还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤), TopicDto(id=85639, encryptionId=3d378563931, topicName=腹腔镜胃癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69295419043, createdName=ms1000000075544727, createdTime=Thu Oct 29 12:32:35 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569088, encodeId=5e665690884f, content=你好，我是第一次投，请问这篇杂志的审稿状态在哪里查？我没有找到查询的地方。能否告知？十分感谢！ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, beContent=ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIePhIB651vdPDdouGOeLzK9F6FYIF0SpUq17tylHVhmfkd4ynSaox2S3r4jXiaVd7VmgYFEXBPxqQ/132, createdBy=5ae52347791, createdName=Yuwei5828, createdTime=Wed Apr 03 00:00:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558307, encodeId=0d7755830e28, content=3.10 submit and under review 5.10 major revision 5.23 resubmit and under review 6.12 accept波0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=波0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558075, encodeId=1b235580e517, content=你好.请问接收后proof大概多久能有海0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=海0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555984, encodeId=26265559845c, content=2个月.大修海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, beContent=海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555509, encodeId=92f3555509cb, content=投了一篇，审稿已经有7周了，依然under review，不算快，可能研究领域是罕见病原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Sat Apr 28 13:52:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546072, encodeId=0b4e5460e24b, content=那感觉快啊.请问投稿的格式要求在哪看啊? 奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快.奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BBDCEDA9BBE8FC4FED476B3DFCCDAABE/100, createdBy=427e2125801, createdName=zzczzczzc, createdTime=Wed Aug 30 00:00:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545822, encodeId=312a545822f9, content=刚发了一篇，一审10天，修改20天，返修10天接收。很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54412015424, createdName=奥美拉唑, createdTime=Wed Aug 23 16:44:00 CST 2017, time=2017-08-23, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

什么是correspondingauthor/通讯作者？

59 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093489, encodeId=c23f109348996, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802963, encodeId=fb328029630f, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：腔镜手术 经验分享：提交后没想到5天之后直接接收了。至今遇到最快的一次投稿。不要版面费审稿费，大约1个月内见刊，唯一的缺点就是if太低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95922353921, createdName=Collection3232, createdTime=Thu Jul 16 09:02:37 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895393, encodeId=1381895393cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a><a href='/topic/show?id=3d378563931' target=_blank style='color:#2F92EE;'>#腹腔镜胃癌根治术#</a>投了10天之后给了小修，但最后因为检验效能不够（样本量小）给拒了。不过杂志审稿还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤), TopicDto(id=85639, encryptionId=3d378563931, topicName=腹腔镜胃癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69295419043, createdName=ms1000000075544727, createdTime=Thu Oct 29 12:32:35 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569088, encodeId=5e665690884f, content=你好，我是第一次投，请问这篇杂志的审稿状态在哪里查？我没有找到查询的地方。能否告知？十分感谢！ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, beContent=ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIePhIB651vdPDdouGOeLzK9F6FYIF0SpUq17tylHVhmfkd4ynSaox2S3r4jXiaVd7VmgYFEXBPxqQ/132, createdBy=5ae52347791, createdName=Yuwei5828, createdTime=Wed Apr 03 00:00:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558307, encodeId=0d7755830e28, content=3.10 submit and under review 5.10 major revision 5.23 resubmit and under review 6.12 accept波0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=波0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558075, encodeId=1b235580e517, content=你好.请问接收后proof大概多久能有海0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=海0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555984, encodeId=26265559845c, content=2个月.大修海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, beContent=海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555509, encodeId=92f3555509cb, content=投了一篇，审稿已经有7周了，依然under review，不算快，可能研究领域是罕见病原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Sat Apr 28 13:52:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546072, encodeId=0b4e5460e24b, content=那感觉快啊.请问投稿的格式要求在哪看啊? 奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快.奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BBDCEDA9BBE8FC4FED476B3DFCCDAABE/100, createdBy=427e2125801, createdName=zzczzczzc, createdTime=Wed Aug 30 00:00:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545822, encodeId=312a545822f9, content=刚发了一篇，一审10天，修改20天，返修10天接收。很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54412015424, createdName=奥美拉唑, createdTime=Wed Aug 23 16:44:00 CST 2017, time=2017-08-23, status=1, ipAttribution=)]

2020-07-16 Collection3232

审稿速度:1.0 | 投稿命中率:100.0
偏重的研究方向：腔镜手术
经验分享：提交后没想到5天之后直接接收了。至今遇到最快的一次投稿。不要版面费审稿费，大约1个月内见刊，唯一的缺点就是if太低了。

168 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093489, encodeId=c23f109348996, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802963, encodeId=fb328029630f, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：腔镜手术 经验分享：提交后没想到5天之后直接接收了。至今遇到最快的一次投稿。不要版面费审稿费，大约1个月内见刊，唯一的缺点就是if太低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95922353921, createdName=Collection3232, createdTime=Thu Jul 16 09:02:37 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895393, encodeId=1381895393cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a><a href='/topic/show?id=3d378563931' target=_blank style='color:#2F92EE;'>#腹腔镜胃癌根治术#</a>投了10天之后给了小修，但最后因为检验效能不够（样本量小）给拒了。不过杂志审稿还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤), TopicDto(id=85639, encryptionId=3d378563931, topicName=腹腔镜胃癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69295419043, createdName=ms1000000075544727, createdTime=Thu Oct 29 12:32:35 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569088, encodeId=5e665690884f, content=你好，我是第一次投，请问这篇杂志的审稿状态在哪里查？我没有找到查询的地方。能否告知？十分感谢！ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, beContent=ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIePhIB651vdPDdouGOeLzK9F6FYIF0SpUq17tylHVhmfkd4ynSaox2S3r4jXiaVd7VmgYFEXBPxqQ/132, createdBy=5ae52347791, createdName=Yuwei5828, createdTime=Wed Apr 03 00:00:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558307, encodeId=0d7755830e28, content=3.10 submit and under review 5.10 major revision 5.23 resubmit and under review 6.12 accept波0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=波0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558075, encodeId=1b235580e517, content=你好.请问接收后proof大概多久能有海0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=海0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555984, encodeId=26265559845c, content=2个月.大修海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, beContent=海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555509, encodeId=92f3555509cb, content=投了一篇，审稿已经有7周了，依然under review，不算快，可能研究领域是罕见病原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Sat Apr 28 13:52:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546072, encodeId=0b4e5460e24b, content=那感觉快啊.请问投稿的格式要求在哪看啊? 奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快.奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BBDCEDA9BBE8FC4FED476B3DFCCDAABE/100, createdBy=427e2125801, createdName=zzczzczzc, createdTime=Wed Aug 30 00:00:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545822, encodeId=312a545822f9, content=刚发了一篇，一审10天，修改20天，返修10天接收。很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54412015424, createdName=奥美拉唑, createdTime=Wed Aug 23 16:44:00 CST 2017, time=2017-08-23, status=1, ipAttribution=)]

2020-10-29 ms1000000075544727

审稿速度:1.0 | 投稿命中率:50.0
经验分享：#肿瘤##腹腔镜胃癌根治术#投了10天之后给了小修，但最后因为检验效能不够（样本量小）给拒了。不过杂志审稿还是比较快的。

181 0

[GetPortalCommentsPageByObjectIdResponse(id=1093489, encodeId=c23f109348996, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802963, encodeId=fb328029630f, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：腔镜手术 经验分享：提交后没想到5天之后直接接收了。至今遇到最快的一次投稿。不要版面费审稿费，大约1个月内见刊，唯一的缺点就是if太低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95922353921, createdName=Collection3232, createdTime=Thu Jul 16 09:02:37 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895393, encodeId=1381895393cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a><a href='/topic/show?id=3d378563931' target=_blank style='color:#2F92EE;'>#腹腔镜胃癌根治术#</a>投了10天之后给了小修，但最后因为检验效能不够（样本量小）给拒了。不过杂志审稿还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤), TopicDto(id=85639, encryptionId=3d378563931, topicName=腹腔镜胃癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69295419043, createdName=ms1000000075544727, createdTime=Thu Oct 29 12:32:35 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569088, encodeId=5e665690884f, content=你好，我是第一次投，请问这篇杂志的审稿状态在哪里查？我没有找到查询的地方。能否告知？十分感谢！ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, beContent=ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIePhIB651vdPDdouGOeLzK9F6FYIF0SpUq17tylHVhmfkd4ynSaox2S3r4jXiaVd7VmgYFEXBPxqQ/132, createdBy=5ae52347791, createdName=Yuwei5828, createdTime=Wed Apr 03 00:00:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558307, encodeId=0d7755830e28, content=3.10 submit and under review 5.10 major revision 5.23 resubmit and under review 6.12 accept波0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=波0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558075, encodeId=1b235580e517, content=你好.请问接收后proof大概多久能有海0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=海0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555984, encodeId=26265559845c, content=2个月.大修海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, beContent=海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555509, encodeId=92f3555509cb, content=投了一篇，审稿已经有7周了，依然under review，不算快，可能研究领域是罕见病原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Sat Apr 28 13:52:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546072, encodeId=0b4e5460e24b, content=那感觉快啊.请问投稿的格式要求在哪看啊? 奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快.奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BBDCEDA9BBE8FC4FED476B3DFCCDAABE/100, createdBy=427e2125801, createdName=zzczzczzc, createdTime=Wed Aug 30 00:00:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545822, encodeId=312a545822f9, content=刚发了一篇，一审10天，修改20天，返修10天接收。很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54412015424, createdName=奥美拉唑, createdTime=Wed Aug 23 16:44:00 CST 2017, time=2017-08-23, status=1, ipAttribution=)]

2019-04-03 Yuwei5828

你好，我是第一次投，请问这篇杂志的审稿状态在哪里查？我没有找到查询的地方。能否告知？十分感谢！ss1002 2017-01-28 11:05:00 发表:
submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。

ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。

197 0

[GetPortalCommentsPageByObjectIdResponse(id=1093489, encodeId=c23f109348996, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802963, encodeId=fb328029630f, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：腔镜手术 经验分享：提交后没想到5天之后直接接收了。至今遇到最快的一次投稿。不要版面费审稿费，大约1个月内见刊，唯一的缺点就是if太低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95922353921, createdName=Collection3232, createdTime=Thu Jul 16 09:02:37 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895393, encodeId=1381895393cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a><a href='/topic/show?id=3d378563931' target=_blank style='color:#2F92EE;'>#腹腔镜胃癌根治术#</a>投了10天之后给了小修，但最后因为检验效能不够（样本量小）给拒了。不过杂志审稿还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤), TopicDto(id=85639, encryptionId=3d378563931, topicName=腹腔镜胃癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69295419043, createdName=ms1000000075544727, createdTime=Thu Oct 29 12:32:35 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569088, encodeId=5e665690884f, content=你好，我是第一次投，请问这篇杂志的审稿状态在哪里查？我没有找到查询的地方。能否告知？十分感谢！ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, beContent=ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIePhIB651vdPDdouGOeLzK9F6FYIF0SpUq17tylHVhmfkd4ynSaox2S3r4jXiaVd7VmgYFEXBPxqQ/132, createdBy=5ae52347791, createdName=Yuwei5828, createdTime=Wed Apr 03 00:00:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558307, encodeId=0d7755830e28, content=3.10 submit and under review 5.10 major revision 5.23 resubmit and under review 6.12 accept波0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=波0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558075, encodeId=1b235580e517, content=你好.请问接收后proof大概多久能有海0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=海0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555984, encodeId=26265559845c, content=2个月.大修海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, beContent=海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555509, encodeId=92f3555509cb, content=投了一篇，审稿已经有7周了，依然under review，不算快，可能研究领域是罕见病原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Sat Apr 28 13:52:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546072, encodeId=0b4e5460e24b, content=那感觉快啊.请问投稿的格式要求在哪看啊? 奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快.奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BBDCEDA9BBE8FC4FED476B3DFCCDAABE/100, createdBy=427e2125801, createdName=zzczzczzc, createdTime=Wed Aug 30 00:00:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545822, encodeId=312a545822f9, content=刚发了一篇，一审10天，修改20天，返修10天接收。很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54412015424, createdName=奥美拉唑, createdTime=Wed Aug 23 16:44:00 CST 2017, time=2017-08-23, status=1, ipAttribution=)]

2018-06-26 波0

3.10 submit and under review 5.10 major revision 5.23 resubmit and under review 6.12 accept波0 2018-05-11 00:00:00 发表:
2个月.大修

波0 2018-05-11 00:00:00 发表: 2个月.大修

258 0

[GetPortalCommentsPageByObjectIdResponse(id=1093489, encodeId=c23f109348996, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802963, encodeId=fb328029630f, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：腔镜手术 经验分享：提交后没想到5天之后直接接收了。至今遇到最快的一次投稿。不要版面费审稿费，大约1个月内见刊，唯一的缺点就是if太低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95922353921, createdName=Collection3232, createdTime=Thu Jul 16 09:02:37 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895393, encodeId=1381895393cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a><a href='/topic/show?id=3d378563931' target=_blank style='color:#2F92EE;'>#腹腔镜胃癌根治术#</a>投了10天之后给了小修，但最后因为检验效能不够（样本量小）给拒了。不过杂志审稿还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤), TopicDto(id=85639, encryptionId=3d378563931, topicName=腹腔镜胃癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69295419043, createdName=ms1000000075544727, createdTime=Thu Oct 29 12:32:35 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569088, encodeId=5e665690884f, content=你好，我是第一次投，请问这篇杂志的审稿状态在哪里查？我没有找到查询的地方。能否告知？十分感谢！ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, beContent=ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIePhIB651vdPDdouGOeLzK9F6FYIF0SpUq17tylHVhmfkd4ynSaox2S3r4jXiaVd7VmgYFEXBPxqQ/132, createdBy=5ae52347791, createdName=Yuwei5828, createdTime=Wed Apr 03 00:00:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558307, encodeId=0d7755830e28, content=3.10 submit and under review 5.10 major revision 5.23 resubmit and under review 6.12 accept波0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=波0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558075, encodeId=1b235580e517, content=你好.请问接收后proof大概多久能有海0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=海0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555984, encodeId=26265559845c, content=2个月.大修海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, beContent=海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555509, encodeId=92f3555509cb, content=投了一篇，审稿已经有7周了，依然under review，不算快，可能研究领域是罕见病原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Sat Apr 28 13:52:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546072, encodeId=0b4e5460e24b, content=那感觉快啊.请问投稿的格式要求在哪看啊? 奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快.奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BBDCEDA9BBE8FC4FED476B3DFCCDAABE/100, createdBy=427e2125801, createdName=zzczzczzc, createdTime=Wed Aug 30 00:00:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545822, encodeId=312a545822f9, content=刚发了一篇，一审10天，修改20天，返修10天接收。很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54412015424, createdName=奥美拉唑, createdTime=Wed Aug 23 16:44:00 CST 2017, time=2017-08-23, status=1, ipAttribution=)]

2018-06-18 ebetheone

你好.请问接收后proof大概多久能有海0 2018-05-11 00:00:00 发表:
2个月.大修

海0 2018-05-11 00:00:00 发表: 2个月.大修

215 0

[GetPortalCommentsPageByObjectIdResponse(id=1093489, encodeId=c23f109348996, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802963, encodeId=fb328029630f, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：腔镜手术 经验分享：提交后没想到5天之后直接接收了。至今遇到最快的一次投稿。不要版面费审稿费，大约1个月内见刊，唯一的缺点就是if太低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95922353921, createdName=Collection3232, createdTime=Thu Jul 16 09:02:37 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895393, encodeId=1381895393cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a><a href='/topic/show?id=3d378563931' target=_blank style='color:#2F92EE;'>#腹腔镜胃癌根治术#</a>投了10天之后给了小修，但最后因为检验效能不够（样本量小）给拒了。不过杂志审稿还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤), TopicDto(id=85639, encryptionId=3d378563931, topicName=腹腔镜胃癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69295419043, createdName=ms1000000075544727, createdTime=Thu Oct 29 12:32:35 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569088, encodeId=5e665690884f, content=你好，我是第一次投，请问这篇杂志的审稿状态在哪里查？我没有找到查询的地方。能否告知？十分感谢！ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, beContent=ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIePhIB651vdPDdouGOeLzK9F6FYIF0SpUq17tylHVhmfkd4ynSaox2S3r4jXiaVd7VmgYFEXBPxqQ/132, createdBy=5ae52347791, createdName=Yuwei5828, createdTime=Wed Apr 03 00:00:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558307, encodeId=0d7755830e28, content=3.10 submit and under review 5.10 major revision 5.23 resubmit and under review 6.12 accept波0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=波0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558075, encodeId=1b235580e517, content=你好.请问接收后proof大概多久能有海0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=海0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555984, encodeId=26265559845c, content=2个月.大修海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, beContent=海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555509, encodeId=92f3555509cb, content=投了一篇，审稿已经有7周了，依然under review，不算快，可能研究领域是罕见病原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Sat Apr 28 13:52:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546072, encodeId=0b4e5460e24b, content=那感觉快啊.请问投稿的格式要求在哪看啊? 奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快.奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BBDCEDA9BBE8FC4FED476B3DFCCDAABE/100, createdBy=427e2125801, createdName=zzczzczzc, createdTime=Wed Aug 30 00:00:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545822, encodeId=312a545822f9, content=刚发了一篇，一审10天，修改20天，返修10天接收。很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54412015424, createdName=奥美拉唑, createdTime=Wed Aug 23 16:44:00 CST 2017, time=2017-08-23, status=1, ipAttribution=)]

2018-05-11 波0

2个月.大修海0 2018-04-28 13:52:00 发表:
投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因

海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因

324 0

[GetPortalCommentsPageByObjectIdResponse(id=1093489, encodeId=c23f109348996, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802963, encodeId=fb328029630f, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：腔镜手术 经验分享：提交后没想到5天之后直接接收了。至今遇到最快的一次投稿。不要版面费审稿费，大约1个月内见刊，唯一的缺点就是if太低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95922353921, createdName=Collection3232, createdTime=Thu Jul 16 09:02:37 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895393, encodeId=1381895393cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a><a href='/topic/show?id=3d378563931' target=_blank style='color:#2F92EE;'>#腹腔镜胃癌根治术#</a>投了10天之后给了小修，但最后因为检验效能不够（样本量小）给拒了。不过杂志审稿还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤), TopicDto(id=85639, encryptionId=3d378563931, topicName=腹腔镜胃癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69295419043, createdName=ms1000000075544727, createdTime=Thu Oct 29 12:32:35 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569088, encodeId=5e665690884f, content=你好，我是第一次投，请问这篇杂志的审稿状态在哪里查？我没有找到查询的地方。能否告知？十分感谢！ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, beContent=ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIePhIB651vdPDdouGOeLzK9F6FYIF0SpUq17tylHVhmfkd4ynSaox2S3r4jXiaVd7VmgYFEXBPxqQ/132, createdBy=5ae52347791, createdName=Yuwei5828, createdTime=Wed Apr 03 00:00:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558307, encodeId=0d7755830e28, content=3.10 submit and under review 5.10 major revision 5.23 resubmit and under review 6.12 accept波0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=波0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558075, encodeId=1b235580e517, content=你好.请问接收后proof大概多久能有海0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=海0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555984, encodeId=26265559845c, content=2个月.大修海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, beContent=海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555509, encodeId=92f3555509cb, content=投了一篇，审稿已经有7周了，依然under review，不算快，可能研究领域是罕见病原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Sat Apr 28 13:52:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546072, encodeId=0b4e5460e24b, content=那感觉快啊.请问投稿的格式要求在哪看啊? 奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快.奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BBDCEDA9BBE8FC4FED476B3DFCCDAABE/100, createdBy=427e2125801, createdName=zzczzczzc, createdTime=Wed Aug 30 00:00:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545822, encodeId=312a545822f9, content=刚发了一篇，一审10天，修改20天，返修10天接收。很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54412015424, createdName=奥美拉唑, createdTime=Wed Aug 23 16:44:00 CST 2017, time=2017-08-23, status=1, ipAttribution=)]

2018-04-28 波0

投了一篇，审稿已经有7周了，依然under review，不算快，可能研究领域是罕见病原因

305 0

[GetPortalCommentsPageByObjectIdResponse(id=1093489, encodeId=c23f109348996, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802963, encodeId=fb328029630f, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：腔镜手术 经验分享：提交后没想到5天之后直接接收了。至今遇到最快的一次投稿。不要版面费审稿费，大约1个月内见刊，唯一的缺点就是if太低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95922353921, createdName=Collection3232, createdTime=Thu Jul 16 09:02:37 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895393, encodeId=1381895393cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a><a href='/topic/show?id=3d378563931' target=_blank style='color:#2F92EE;'>#腹腔镜胃癌根治术#</a>投了10天之后给了小修，但最后因为检验效能不够（样本量小）给拒了。不过杂志审稿还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤), TopicDto(id=85639, encryptionId=3d378563931, topicName=腹腔镜胃癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69295419043, createdName=ms1000000075544727, createdTime=Thu Oct 29 12:32:35 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569088, encodeId=5e665690884f, content=你好，我是第一次投，请问这篇杂志的审稿状态在哪里查？我没有找到查询的地方。能否告知？十分感谢！ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, beContent=ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIePhIB651vdPDdouGOeLzK9F6FYIF0SpUq17tylHVhmfkd4ynSaox2S3r4jXiaVd7VmgYFEXBPxqQ/132, createdBy=5ae52347791, createdName=Yuwei5828, createdTime=Wed Apr 03 00:00:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558307, encodeId=0d7755830e28, content=3.10 submit and under review 5.10 major revision 5.23 resubmit and under review 6.12 accept波0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=波0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558075, encodeId=1b235580e517, content=你好.请问接收后proof大概多久能有海0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=海0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555984, encodeId=26265559845c, content=2个月.大修海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, beContent=海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555509, encodeId=92f3555509cb, content=投了一篇，审稿已经有7周了，依然under review，不算快，可能研究领域是罕见病原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Sat Apr 28 13:52:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546072, encodeId=0b4e5460e24b, content=那感觉快啊.请问投稿的格式要求在哪看啊? 奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快.奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BBDCEDA9BBE8FC4FED476B3DFCCDAABE/100, createdBy=427e2125801, createdName=zzczzczzc, createdTime=Wed Aug 30 00:00:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545822, encodeId=312a545822f9, content=刚发了一篇，一审10天，修改20天，返修10天接收。很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54412015424, createdName=奥美拉唑, createdTime=Wed Aug 23 16:44:00 CST 2017, time=2017-08-23, status=1, ipAttribution=)]

2017-08-30 zzczzczzc

那感觉快啊.请问投稿的格式要求在哪看啊? 奥美拉唑 2017-08-23 发表::
刚发了一篇.一审10天.修改20天.返修10天接收.很快.奥美拉唑 2017-08-23 16:44:00 发表:
刚发了一篇.一审10天.修改20天.返修10天接收.很快.

奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快.

288 0

[GetPortalCommentsPageByObjectIdResponse(id=1093489, encodeId=c23f109348996, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802963, encodeId=fb328029630f, content=审稿速度:1.0 | 投稿命中率:100.0 偏重的研究方向：腔镜手术 经验分享：提交后没想到5天之后直接接收了。至今遇到最快的一次投稿。不要版面费审稿费，大约1个月内见刊，唯一的缺点就是if太低了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95922353921, createdName=Collection3232, createdTime=Thu Jul 16 09:02:37 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895393, encodeId=1381895393cc, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a><a href='/topic/show?id=3d378563931' target=_blank style='color:#2F92EE;'>#腹腔镜胃癌根治术#</a>投了10天之后给了小修，但最后因为检验效能不够（样本量小）给拒了。不过杂志审稿还是比较快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤), TopicDto(id=85639, encryptionId=3d378563931, topicName=腹腔镜胃癌根治术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69295419043, createdName=ms1000000075544727, createdTime=Thu Oct 29 12:32:35 CST 2020, time=2020-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569088, encodeId=5e665690884f, content=你好，我是第一次投，请问这篇杂志的审稿状态在哪里查？我没有找到查询的地方。能否告知？十分感谢！ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, beContent=ss1002 2017-01-28 11:05:00 发表: submitted ：21-Dec-2016, Revision :30-Dec-2016,revision has been submitted :05-Jan-2017,Accept (20-Jan-2017)。感觉编辑和审稿人都比较友好，问了好几个问题，但不刁钻，更象同行之间的交流。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIePhIB651vdPDdouGOeLzK9F6FYIF0SpUq17tylHVhmfkd4ynSaox2S3r4jXiaVd7VmgYFEXBPxqQ/132, createdBy=5ae52347791, createdName=Yuwei5828, createdTime=Wed Apr 03 00:00:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558307, encodeId=0d7755830e28, content=3.10 submit and under review 5.10 major revision 5.23 resubmit and under review 6.12 accept波0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=波0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Tue Jun 26 00:00:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558075, encodeId=1b235580e517, content=你好.请问接收后proof大概多久能有海0 2018-05-11 00:00:00 发表: 2个月.大修, beContent=海0 2018-05-11 00:00:00 发表: 2个月.大修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f19d2279246, createdName=ebetheone, createdTime=Mon Jun 18 00:00:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555984, encodeId=26265559845c, content=2个月.大修海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, beContent=海0 2018-04-28 13:52:00 发表: 投了一篇.审稿已经有7周了.依然under review.不算快.可能研究领域是罕见病原因, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Fri May 11 00:00:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555509, encodeId=92f3555509cb, content=投了一篇，审稿已经有7周了，依然under review，不算快，可能研究领域是罕见病原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f3c1739990, createdName=波0, createdTime=Sat Apr 28 13:52:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546072, encodeId=0b4e5460e24b, content=那感觉快啊.请问投稿的格式要求在哪看啊? 奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快.奥美拉唑 2017-08-23 16:44:00 发表: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., beContent=奥美拉唑 2017-08-23 发表:: 刚发了一篇.一审10天.修改20天.返修10天接收.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=288, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/BBDCEDA9BBE8FC4FED476B3DFCCDAABE/100, createdBy=427e2125801, createdName=zzczzczzc, createdTime=Wed Aug 30 00:00:00 CST 2017, time=2017-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545822, encodeId=312a545822f9, content=刚发了一篇，一审10天，修改20天，返修10天接收。很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54412015424, createdName=奥美拉唑, createdTime=Wed Aug 23 16:44:00 CST 2017, time=2017-08-23, status=1, ipAttribution=)]

2017-08-23 奥美拉唑

刚发了一篇，一审10天，修改20天，返修10天接收。很快。

219 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务